Table 4.
The association of CD302 or FABP5 expression with clinical features in LGG patients.
| Variables | No. of patient | CD302 expression | χ2 | p value | FABP5 expression | χ2 | p value | ||
|---|---|---|---|---|---|---|---|---|---|
|
Upper 25% |
Lower 75% |
Upper 25% |
Lower 75% |
||||||
| Histologic grade | 22.981 | < 0.001 | 12.836 | < 0.001 | |||||
| G2 | 255 | 40 | 215 | 46 | 209 | ||||
| G3 | 269 | 91 | 178 | 85 | 184 | ||||
| Unknown | 1 | ||||||||
| Therapy outcome | 29.313 | < 0.001 | 28.983 | < 0.001 | |||||
| Complete response | 133 | 17 | 116 | 17 | 116 | ||||
| Partial response | 65 | 11 | 54 | 10 | 55 | ||||
| Progressive disease | 114 | 47 | 67 | 46 | 68 | ||||
| Stable disease | 137 | 34 | 103 | 32 | 105 | ||||
| Unknown | 76 | ||||||||